Collectively, this is the very first study to demonstrate the interplay between RIPK1 and TLR3 signaling in CCA and therapeutic targeting TLR3 by TLR3 ligands in combination with Smac mimetic could bring a new therapeutic concept with more effective for CCA patients. The gene discussed is TLR3; the disease is cholangiocarcinoma.